Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2–AKT–TGF-β Signaling Axis in Pancreatic Cancer
0303 health sciences
Cachexia
Muscles
RNA, Circular
Article
3. Good health
Pancreatic Neoplasms
Mice
MicroRNAs
03 medical and health sciences
Transforming Growth Factor beta
Cell Line, Tumor
Phosphoprotein Phosphatases
Animals
Humans
Cyclin D1
Proto-Oncogene Proteins c-akt
Cell Proliferation
DOI:
10.1053/j.gastro.2022.02.017
Publication Date:
2022-02-14T16:02:20Z
AUTHORS (11)
ABSTRACT
Background & AimsPancreatic cancer has the highest prevalence of cancer-associated cachexia among all cancers. ZIP4 promotes pancreatic progression by regulating oncogenic miR-373, and perturbation circular RNAs (circRNAs) is associated with aggressiveness. This study aimed to identify circRNAs involved in ZIP4/miR-373–driven growth decipher underlying mechanism.MethodsDifferentially expressed potential targets microRNA were identified through silico analysis. The RNA interactions determined means biotinylated pulldown, immunoprecipitation, luciferase reporter assays. function circRNA ZIP4–miR-373 signaling axis examined human cells, 3-dimensional spheroids organoids, mouse models, clinical specimens. Mouse skeletal muscles analyzed histology.ResultsWe circANAPC7 as a sponge for which inhibited tumor muscle wasting vitro vivo. Mechanistic studies showed that PHLPP2 downstream target ZIP4/miR-373. CircANAPC7 functions PHLPP2-mediated dephosphorylation AKT, thus suppressing cell proliferation down-regulating cyclin D1 inhibiting via decreasing secretion transforming factor–β STAT5. We further demonstrated induced CREB, zinc-dependent transcription factor activated ZIP4, thereby forming CREB–miR-373–PHLPP2 feed-forward loop regulate cachexia.ConclusionThis novel suppressor, axis, leading AKT dephosphorylation, down-regulation suppress cancer. Pancreatic mechanism. Differentially histology. cachexia.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (75)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....